S. KLUTCHKO - Concepedia

Author

S. KLUTCHKO

Also Known As

S Klutchko, S R Klutchko, S. KLUTCHKO, S. Klutchko, S. R. KLUTCHKO, SYLVESTER KLUTCHKO, Sylvester KLUTCHKO, Sylvester Klutchko, Sylvester R. Klutchko

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

S. KLUTCHKO is an author at Pfizer (United States) specializing in pharmacology, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	948
2	Engineering	9	9	229
3	Arts	1	1	26
4	Health Sciences	1	1	96
5	Management	1	1	26

S. KLUTCHKO

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors William C. Patt, Harriet W. Hamilton, Michael D. Taylor, Journal of Medicinal Chemistry Medicinal ChemistryHypertensionRenin InhibitorsMonkey ReninMedicine	1992	371
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype C. John Blankley, John C. Hodges, S. KLUTCHKO, Journal of Medicinal Chemistry PharmacotherapyAng IiMedicinal ChemistryAng Ii ReceptorNovel Series	1991	161
2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity S. KLUTCHKO, James M. Hamby, Diane H. Boschelli, Journal of Medicinal Chemistry	1998	130
Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma, Investigational New Drugs Anti-angiogenic ActivityAngiogenesisPhotodynamic TherapyMedicinePhototoxicity	1999	96
In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor Robert L. Panek, Gina H. Lu, S. KLUTCHKO, Journal of Pharmacology and Experimental Therapeutics	1997	94
Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidines: Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors Diane H. Boschelli, Zhipei Wu, S. KLUTCHKO, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryPharmacotherapyCompound LibraryChemical Biology	1998	84
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types S. KLUTCHKO, C. John Blankley, Robert W. Fleming, Journal of Medicinal Chemistry Vitro PotencyPharmaceutical ScienceEnzyme Inhibitor QuinaprilPharmacotherapyChemical Biology	1986	82
Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors S. KLUTCHKO, Hairong Zhou, R. Thomas Winters, Journal of Medicinal Chemistry	2006	79
Heterocyclic synthesis with β‐ketosulfoxides IV. Synthesis of 3‐substituted chromones S. KLUTCHKO, Marvin P. Cohen, John Shavel, Journal of Heterocyclic Chemistry DerivativesEngineeringHeterocyclicNatural SciencesDiversity-oriented Synthesis	1974	72
Heterocyclic syntheses with β‐ketosulfoxides. I. New syntheses of chromones, flavones, thioindigo and thioflavones M. Von Strandtmann, S. KLUTCHKO, Marvin P. Cohen, Journal of Heterocyclic Chemistry EngineeringHeterocyclicBiochemistryNatural SciencesHeterocyclic Syntheses	1972	39

Page 1